Amazon's (AMZN) PillPack Acquisition Is The Foothold Into Healthcare - Deutsche Bank

September 11, 2018 6:49 AM EDT
Get Alerts AMZN Hot Sheet
Price: $114.25 -3.19%

Rating Summary:
    57 Buy, 4 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 9 | New: 34
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Deutsche Bank analyst, Lloyd Walmsley,reiterated his Buy raitng on shares of (NASDAQ: AMZN) on the belief that the ~$1B acquisition of PillPack (pharmacy licenses in 49 states) could accelerate Amazon's move into healthcare more broadly, increasing the value of the Prime service and overall consumer wallet share. Today, PillPack delivers pre packaged medications, coordinates refills and renewals, and makes sure shipments are sent on time.

The analyst stated "We see Amazon likely to expand this effort to helping customers more holistically manage health, using prescription information to help educate customers on their conditions and merchandise over-the-counter medicine, healthcare supplies and healthy food to customers and to sell advertising. Amazon is further looking at healthcare through its JV with Berkshire
Hathaway and JP Morgan, which just hired a COO. Amazon has a history of starting small, testing the market and fine-tuning the service, before launching a full fledged commercial operations. As such, we believe it is a question of when and where – and not if – Amazon enters the healthcare space more forcefully".

No change to the price target of $2,300.

For an analyst ratings summary and ratings history on click here. For more ratings news on click here.

Shares of closed at $1933.00 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments

Related Entities

Deutsche Bank, JPMorgan, Definitive Agreement